At the cellular level transcriptional actions of EGFR were potentiated by glucose and pathway analysis identified the serum response factor (SRF) as an activated vascular transcription regulator during T2DM/obesity. The gene discussed is EGFR; the disease is type 2 diabetes mellitus.